Scott C. Brun

Insider Reports History

Entity
Individual
Location
C/O Cabaletta Bio, Inc., 2929 Arch Street, Suite 600, Philadelphia, PA
Signature
/s/ Paul A. Wagner, Ph.D., as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Scott C. Brun:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Forte Biosciences, Inc. Director Stock Option (right to buy) 50K Aug 20, 2024 Direct
Cabaletta Bio, Inc. Director Stock Option (Right to Buy) 22K Jun 3, 2024 Direct
Jasper Therapeutics, Inc. Director Stock Option (right to buy) 7.5K Jun 6, 2024 Direct

Insider Reports Filed by Scott C. Brun

Symbol Company Period Transactions Value $ Form Type Date Filed Role
FBRX Forte Biosciences, Inc. Aug 20, 2024 1 $0 4 Aug 22, 2024 Director
JSPR Jasper Therapeutics, Inc. Jun 6, 2024 1 $0 4 Jun 10, 2024 Director
CABA Cabaletta Bio, Inc. Jun 3, 2024 1 $0 4 Jun 4, 2024 Director
FBRX Forte Biosciences, Inc. Sep 19, 2023 1 $0 4 Sep 20, 2023 Director
JSPR Jasper Therapeutics, Inc. Jun 20, 2023 1 $0 4 Jun 20, 2023 Director
JSPR Jasper Therapeutics, Inc. Jun 20, 2023 0 $0 3 Jun 20, 2023 Director
CABA Cabaletta Bio, Inc. Jun 1, 2023 1 $0 4 Jun 2, 2023 Director
FBRX Forte Biosciences, Inc. Nov 10, 2022 1 $0 4 Nov 14, 2022 Director
FBRX Forte Biosciences, Inc. Nov 10, 2022 0 $0 3 Nov 14, 2022 Director
CABA Cabaletta Bio, Inc. Jun 1, 2022 1 $0 4 Jun 3, 2022 Director
CABA Cabaletta Bio, Inc. Jun 24, 2021 1 $0 4 Jun 28, 2021 Director
CABA Cabaletta Bio, Inc. Jun 24, 2021 0 $0 3 Jun 28, 2021 Director